Dr. Kah Whye Peng, PhD

Claim this profile
Studies Lymphoma
Studies Cold sores
1 reported clinical trial
3 drugs studied

Clinical Trials Kah Whye Peng, PhD is currently running

Image of trial facility.

Modified Virus and Immunotherapy

for T-Cell Lymphoma

This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus (VSV) carrying the human (h) sodium iodide symporter (NIS) and Interferon (IFN) beta (β) genes (VSV-hIFNβ-NIS) in combination with ipilimumab and cemiplimab in patients with T-cell lymphoma. A virus, called VSV-hIFNβ-NIS, which has been changed in a certain way, may be able to kill cancer cells without damaging normal cells. Immunotherapy with ipilmumab and cemiplimab may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 15 criteria

More about Kah Whye Peng, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kah Whye Peng, PhD has experience with
  • Cemiplimab
  • Ipilimumab
  • Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta And Sodium-Iodide Symporter
Breakdown of trials Kah Whye Peng, PhD has run
Lymphoma
Cold sores
Non-Hodgkin's Lymphoma
Anaplastic Large Cell Lymphoma
Fungal Infection

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kah Whye Peng, PhD specialize in?
Kah Whye Peng, PhD focuses on Lymphoma and Cold sores. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Kah Whye Peng, PhD currently recruiting for clinical trials?
Yes, Kah Whye Peng, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Kah Whye Peng, PhD has studied deeply?
Yes, Kah Whye Peng, PhD has studied treatments such as Cemiplimab, Ipilimumab, Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter.
What is the best way to schedule an appointment with Kah Whye Peng, PhD?
Apply for one of the trials that Kah Whye Peng, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top